111 related articles for article (PubMed ID: 15210852)
1. Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells.
Salvi A; Arici B; De Petro G; Barlati S
Mol Cancer Ther; 2004 Jun; 3(6):671-8. PubMed ID: 15210852
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.
Tavian D; Salvi A; De Petro G; Barlati S
Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199
[TBL] [Abstract][Full Text] [Related]
3. RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice.
Salvi A; Arici B; Alghisi A; Barlati S; De Petro G
Tumour Biol; 2007; 28(1):16-26. PubMed ID: 17159381
[TBL] [Abstract][Full Text] [Related]
4. Dioscorea nipponica Attenuates Migration and Invasion by Inhibition of Urokinase-Type Plasminogen Activator through Involving PI3K/Akt and Transcriptional Inhibition of NF-[Formula: see text]B and SP-1 in Hepatocellular Carcinoma.
Hsieh MJ; Yeh CB; Chiou HL; Hsieh MC; Yang SF
Am J Chin Med; 2016; 44(1):177-95. PubMed ID: 26916922
[TBL] [Abstract][Full Text] [Related]
5. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference.
Wang L; Wu G; Yu L; Yuan J; Fang F; Zhai Z; Wang F; Wang H
Cancer Biol Ther; 2006 Jun; 5(6):608-14. PubMed ID: 16627983
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
[TBL] [Abstract][Full Text] [Related]
9. Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients.
Fibbi G; Barletta E; Dini G; Del Rosso A; Pucci M; Cerletti M; Del Rosso M
Lab Invest; 2001 Jan; 81(1):27-39. PubMed ID: 11204271
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.
Kondraganti S; Gondi CS; McCutcheon I; Dinh DH; Gujrati M; Rao JS; Olivero WC
Int J Oncol; 2006 Jun; 28(6):1353-60. PubMed ID: 16685436
[TBL] [Abstract][Full Text] [Related]
11. Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.
Tsai JP; Hsiao PC; Yang SF; Hsieh SC; Bau DT; Ling CL; Pai CL; Hsieh YH
PLoS One; 2014; 9(1):e86537. PubMed ID: 24466137
[TBL] [Abstract][Full Text] [Related]
12. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
Salvi A; Arici B; Portolani N; Giulini SM; De Petro G; Barlati S
Int J Oncol; 2007 Aug; 31(2):451-60. PubMed ID: 17611703
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
[TBL] [Abstract][Full Text] [Related]
14. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
[TBL] [Abstract][Full Text] [Related]
15. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
16. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
[TBL] [Abstract][Full Text] [Related]
17. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
18. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity.
Clayman G; Wang SW; Nicolson GL; el-Naggar A; Mazar A; Henkin J; Blasi F; Goepfert H; Boyd DD
Int J Cancer; 1993 Apr; 54(1):73-80. PubMed ID: 8386710
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.
Salvi A; Bongarzone I; Miccichè F; Arici B; Barlati S; De Petro G
Neoplasia; 2009 Feb; 11(2):207-19. PubMed ID: 19177205
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms.
Jin Y; Liang ZY; Zhou WX; Zhou L
Hepatol Int; 2019 Mar; 13(2):180-189. PubMed ID: 30600477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
